These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15520413)

  • 1. The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells.
    Hellstrand M; Danielsen EA; Steen VM; Ekman A; Eriksson E; Nilsson CL
    J Med Genet; 2004 Nov; 41(11):867-71. PubMed ID: 15520413
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine D2 receptor signaling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2.
    Piomelli D; Di Marzo V
    J Lipid Mediat; 1993; 6(1-3):433-43. PubMed ID: 8395253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system.
    Lundstrom K; Turpin MP
    Biochem Biophys Res Commun; 1996 Aug; 225(3):1068-72. PubMed ID: 8780735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein enhances dopamine D2 receptor signaling.
    Kim SJ; Kim SY; Na YS; Lee HJ; Chung KC; Baik JH
    Brain Res; 2006 Dec; 1124(1):5-9. PubMed ID: 17087919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling.
    Basile M; Lin R; Kabbani N; Karpa K; Kilimann M; Simpson I; Kester M
    Arch Biochem Biophys; 2006 Feb; 446(1):60-8. PubMed ID: 16386234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cells.
    Hall DA; Strange PG
    Biochem Pharmacol; 1999 Jul; 58(2):285-9. PubMed ID: 10423170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors.
    Kim JH; Cho EY; Min C; Park JH; Kim KM
    Arch Pharm Res; 2008 Apr; 31(4):474-81. PubMed ID: 18449505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the alternatively spliced insert region of the D2L dopamine receptor by epitope substitution.
    Kendall RT; Senogles SE
    Neurosci Lett; 2006 Jan; 393(2-3):155-9. PubMed ID: 16226376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.
    Seeman P; Tokita K; Matsumoto M; Matsuo A; Sasamata M; Miyata K
    Synapse; 2009 Oct; 63(10):930-4. PubMed ID: 19588469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D3 dopamine receptor: neurobiology and potential clinical relevance.
    Levant B
    Pharmacol Rev; 1997 Sep; 49(3):231-52. PubMed ID: 9311022
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
    Jordan S; Chen R; Fernalld R; Johnson J; Regardie K; Kambayashi J; Tadori Y; Kitagawa H; Kikuchi T
    Eur J Pharmacol; 2006 Jul; 540(1-3):53-6. PubMed ID: 16730695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor.
    Shemesh R; Hermesh C; Toporik A; Levine Z; Novik A; Wool A; Kliger Y; Rosenberg A; Bathgate RA; Cohen Y
    Ann N Y Acad Sci; 2009 Apr; 1160():78-86. PubMed ID: 19416163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
    Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
    J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.